AstraZeneca wins fresh U.S. funding in race for COVID-19 treatment

0
18
AstraZeneca on Tuesday received $23.7 million in funding from a U.S. government agency to advance the development of antibody-based COVID-19 treatments as the British drugmaker ramps up efforts beyond its potential vaccine to combat the pandemic.

Go to Source
Author: